10/25/23, 9:25 PM
Retinopathy of Prematurity | Auctores
info@mediresonline.org (mailto:info@mediresonline.org) 2656)
+1-(302)-231-2656 (tel:+1-(302)-231-
(https://mediresonline.org/)
Retinopathy of Prematurity Home (https://mediresonline.org/) / Journals (https://mediresonline.org/journals) / Clinical Case Reports and Trails (https://mediresonline.org/journals/clinical-case-reports-and-trails) / Articles In Press (https://mediresonline.org/journals/clinical-case-reports-and-trails/articles-in-press)
Articles
Pdf (https://mediresonline.org/uploads/articles/16
Quick Links
016.pdf) Case
Report
|
DOI:
https://doi.org/10.58489/2836-2217/015
(https://doi.org/10.58489/2836-2217/015)
Retinopathy of Prematurity Dr. Rajeev Gupta
Chairman Central Specialist Committee Royal College of Paediatrics & Child Health, Vice Chairman CESR Committee, Royal College of Paediatrics Ex-Chairman Regional Consultant Committee BMA, Recent Chairman Regional Council British Medical Association, Barnsley Foundation Hospital, United Kingdom. *Corresponding Author: Dr. Rajeev Gupta Citation: Dr. Rajeev Gupta (2023), Retinopathy of Prematurity. Journal of Clinical Case Reports and Trails. 2(1). DOI: 10.58489/2836-2217/015 Copyright: © 2022 Dr. Rajeev Gupta, this is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Received: 03 April 2023 | Accepted: 13 April 2023 | Published: 20 April 2023 Keywords:
Abstract Introduction Retinopathy of prematurity (ROP) is a significant cause of childhood blindness worldwide (1), particularly in low-resource settings. The factors that increase the risk of ROP include sepsis, birth weight, oxygen requirement, red blood cell (RBC) transfusion etc [2 (https://journals.plos.org/plosone/article? id=10.1371/journal.pone.0234266#pone.0234266.ref002) , 3]. ROP affects retinal vascular and capillary proliferation affecting premature infants undergoing oxygen therapy (4). We present the case of a 28-week gestational age premature infant who developed severe ROP and was successfully managed with laser therapy. Regular monitoring, early identification, and early intervention are crucial factors in the management of ROP (5).
Case Report https://mediresonline.org//article/retinopathy-of-prematurity
1/4
10/25/23, 9:25 PM
Retinopathy of Prematurity | Auctores
A female premature infant was born at 28 weeks of gestation with a birth weight of 850 grams by spontaneous birth. Baby has developed respiratory distress syndrome and needed respiratory support in the form of ventilation and continuous positive airway pressure (CPAP) for 3 weeks. The mother has been ill and the baby developed signs of sepsis for which she was treated with intravenous antibiotics for 7 days. The baby needed supplemental oxygen for another 3 weeks. The baby had routine ROP screening at four weeks of age, which revealed stage 2 ROP in zone II of the retina. The baby was monitored closely, but at six weeks of age, the ROP progressed to stage 3 with plus disease, indicating the need for treatment. Due to limited resources, laser therapy was the only available treatment option. The infant underwent laser therapy, with 1300 burns applied to the avascular retina in both eyes. The baby was monitored closely for complications, including infection and retinal detachment, but none were observed. The infant was weaned off oxygen therapy and CPAP and was discharged at 10 weeks of age. Follow-up examinations at one month and three months post-treatment revealed regression of ROP without any residual avascular retina or complications.
Discussion ROP is a significant concern in premature babies who need oxygen for a prolonged period of time. It happens in babies below 32 weeks gestation and those below 1500 grams at birth. ROP and the developing blood vessels in premature eyes are graded according to the stage of severity (stages 1-5) and according to the location in the retina (zones 1-3) and these are standards used internationally (6). Most babies with retinopathy stage 1 or stage 2 will need no intervention and live with normal vision. Since the disease progressed to stage 3 and was progressive, treatment was required. Laser therapy is effective and is applied to the peripheral retina where blood vessels are developing. The overall aim of laser therapy is to turn off the production of a chemical message produced by the retina called the Vascular Endothelial Growth Factor (VEGF); this molecule drives the formation of damaging blood vessels. Laser therapy can be associated with a higher risk of complications, such as inflammation and scarring, and requires specialized equipment and trained personnel. Although cryotherapy and the use of blocking antibodies ‘anti-VEGF injection into the eye to turn off VEGF production are other options, this case responded to laser.
Conclusion ROP is a significant cause of childhood blindness that requires timely screening and appropriate management. Although there are various options, laser therapy is still a good option for managing moderate to severe ROP. Early detection and appropriate management of ROP are critical to prevent permanent vision loss and promote longterm visual health. Further research and innovation in screening and treatment strategies for ROP are needed to improve outcomes particularly in low-resource settings.
References 1. Hartnett ME. Advances in understanding and management of retinopathy of prematurity. Survey of ophthalmology. 2017;62(3):257–76. Epub 2016/12/26. pmid:28012875; PubMed Central PMCID: PMC5401801. View at Publisher | View at Google Scholar 2. Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Survey of https://mediresonline.org//article/retinopathy-of-prematurity
2/4
10/25/23, 9:25 PM
Retinopathy of Prematurity | Auctores
ophthalmology.
2018;63(5):618–37.
Epub
2018/04/22.
pmid:29679617;
PubMed Central PMCID: PMC6089661. View at Publisher | View at Google Scholar 3. Zhu, Z., Hua, X., Yu, Y., Zhu, P., Hong, K., & Ke, Y. (2020). Effect of red blood cell transfusion on the development of retinopathy of prematurity: A systematic review and meta-analysis. PLoS One, 15(6), e0234266. View at Publisher (https://journals.plos.org/plosone/article? id=10.1371/journal.pone.0234266) | View at Google Scholar (https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0234266) 4. Retinopathy of Prematurity View at Publisher (https://www.ncbi.nlm.nih.gov/books/NBK562319/) | View at Google Scholar (https://www.ncbi.nlm.nih.gov/books/NBK562319/) 5. Good, W. V. (2006). Early treatment for retinopathy of prematurity cooperative group. the early treatment for retinopathy of prematurity study: structural findings at age 2 years. Br J Ophthalmol, 90(11), 1378-1382. View at Publisher (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857487/) | View at Google Scholar (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857487/) 6. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity Revisited. Arch Ophthalmol. 2005;123(7):991-999.. View at Publisher | View at Google Scholar
ABOUT MEDIRES Medires Publishers have been established with portfolio of enhancing high impact scientific and medical information with open access and internationally peer-reviewed process disseminating the updated. Read More.. (https://mediresonline.org/about)
QUICK LINKS-365 Home (https://mediresonline.org/) Explore Journals (https://mediresonline.org/journals) Open Access (https://mediresonline.org/open-access) Authors (https://mediresonline.org/authors) Editors (https://mediresonline.org/editors) About Us (https://mediresonline.org/about) Submit Manuscript (https://mediresonline.org/submit-manuscript)
CONTACT INFO Medires PUBLISHING LLC, 447 Broadway, 2nd Floor, Suite #1734, New York, 10013, United States. Phone: +1-(302)-231-2656 Email: info@mediresonline.org (mailto:info@mediresonline.org) Contact Us (We contact you) (https://mediresonline.org/contactus)
https://mediresonline.org//article/retinopathy-of-prematurity
3/4
10/25/23, 9:25 PM
Retinopathy of Prematurity | Auctores © 2022-2023 Medires Online, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use. Creative Commons License Open Access by Medires Online is licensed under (https://creativecommons.org/licenses/by/4.0/) a Creative Commons Attribution 4.0 International License.
https://mediresonline.org//article/retinopathy-of-prematurity
4/4